Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and ...
The U.S. Food and Drug Administration on Thursday found that there was no longer a shortage of Eli Lilly's blockbuster weight ...
Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...
As of today, three other GLP-1 receptor agonists remain on the FDA's shortage list: semaglutide (Ozempic, Wegovy), ...
We recently compiled a list of the 6 Stocks Jim Cramer Talked About This Week. In this article, we are going to take a look ...
The Food and Drug Administration has finalized its decision to call an end to the drug shortage of Eli Lilly's (LLY) ...
Memory-chip maker swung to a profit and posted higher revenue in its fiscal first quarter, though shares fell after the company's outlook missed estimates. CVS ignored substantial evidence from ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
Bloomberg L.P. on MSN8h
Lilly Weight-Loss Drug Shortage in US Has Ended, FDA SaysEli Lilly & Co.’s weight-loss and diabetes drugs Mounjaro and Zepbound are no longer in short supply in the US, which means ...
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback